As Asian markets navigate a landscape shaped by geopolitical tensions and fluctuating energy prices, attention has turned to small-cap stocks that may offer unique opportunities amidst broader market volatility. In this environment, insider activity can serve as a valuable indicator of potential value in these smaller companies, highlighting those that might be poised for growth despite current economic challenges.

Top 10 Undervalued Small Caps With Insider Buying In Asia

Name PE PS Discount to Fair Value Value Rating Security Bank 4.3x 0.9x 29.50% ★★★★★★ Centurion 10.8x 3.7x 36.38% ★★★★★★ Dicker Data 18.8x 0.6x -8.56% ★★★★☆☆ FINEOS Corporation Holdings 606.9x 4.1x 5.41% ★★★★☆☆ SiteMinder NA 3.1x 46.94% ★★★★☆☆ Shoucheng Holdings 45.2x 9.8x 46.12% ★★★☆☆☆ DUG Technology 132.4x 2.8x 20.20% ★★★☆☆☆ HBM Holdings 13.9x 8.0x -27.85% ★★★☆☆☆ CapitaLand China Trust NA 3.8x -0.46% ★★★☆☆☆ Strike Energy NA 6.2x 25.97% ★★★☆☆☆

Click here to see the full list of 64 stocks from our Undervalued Asian Small Caps With Insider Buying screener.

Let's uncover some gems from our specialized screener.

GrainCorp

Simply Wall St Value Rating: ★★★★★☆

Overview: GrainCorp is a leading Australian agribusiness company involved in the storage, handling, marketing and processing of grain and related commodities with a market capitalization of A$2.5 billion.

Operations: The company's revenue is primarily generated from Agribusiness and Nutrition & Energy segments, totaling A$7.49 billion. Over recent periods, the gross profit margin has shown variability, reaching a high of 20.70% in September 2022 but declining to 9.72% by March 2026. Operating expenses have fluctuated alongside changes in revenue and cost structures, impacting overall profitability trends.

PE: -75.0x

GrainCorp's recent financials reveal a challenging period, with sales dropping to A$3.88 billion from A$4.09 billion and net income plummeting to A$4.6 million from A$58.1 million year-on-year for the half-year ending March 31, 2026. Despite these hurdles, insider confidence is evident as key figures purchased shares in early May 2026, signaling potential optimism about future growth prospects. The company relies on external borrowing for funding, which adds risk but also positions it uniquely within its industry context in Asia's smaller companies landscape. Earnings are projected to grow by over 54% annually, suggesting potential recovery and value realization ahead despite current financial strains.

Unlock comprehensive insights into our analysis of GrainCorp stock in this valuation report. Gain insights into GrainCorp's historical performance by reviewing our past performance report.

Story Continues

ASX:GNC Share price vs Value as at May 2026

Perenti

Simply Wall St Value Rating: ★★★★☆☆

Overview: Perenti is a diversified global mining services company providing drilling, contract mining, and technology services, with a market capitalization of A$1.17 billion.

Operations: Perenti's primary revenue streams are Contract Mining Services, generating A$2.48 billion, and Drilling Services with A$812.55 million. The company's gross profit margin has shown a range from 25.65% to 30.29% over the observed periods, reflecting variations in cost efficiencies and pricing strategies relative to its revenues of up to A$3.50 billion by December 2025.

PE: 15.9x

Perenti, a mining services company, has recently seen insider confidence through share purchases over the past six months. Despite lowering its revenue guidance for fiscal year 2026 to A$3.45 billion-A$3.55 billion, the company remains attractive due to its consistent earnings growth and strategic leadership changes. Dr. Vanessa Torres's appointment as CEO in June 2026 brings extensive industry experience, which could drive future growth amid challenging market conditions. The company's reliance on external borrowing suggests potential financial risk but also opportunities for strategic leverage in expanding operations across Asia's competitive landscape.

Click to explore a detailed breakdown of our findings in Perenti's valuation report. Examine Perenti's past performance report to understand how it has performed in the past.ASX:PRN Share price vs Value as at May 2026

HBM Holdings

Simply Wall St Value Rating: ★★★☆☆☆

Overview: HBM Holdings is a biotechnology company with operations focused on developing and commercializing innovative therapies, holding a market cap of approximately HK$2.85 billion.

Operations: HBM Holdings generates revenue primarily from its biotechnology segment. The company has experienced fluctuations in its net income margin, reaching 63.15% by mid-2025. Operating expenses are largely driven by R&D and general & administrative costs, with R&D being a significant component of their expenditure.

PE: 13.9x

HBM Holdings, a biopharmaceutical company, stands out with its innovative antibody therapeutics and recent insider confidence through share purchases in early 2026. The company's financial performance showed significant growth, with sales reaching US$158 million and net income of US$91 million for 2025. Recent FDA clearance for HBM7004's Phase I trial in the U.S. highlights their expanding pipeline. With strategic leadership changes and promising preclinical data on LET003, HBM is positioned to enhance its market presence amidst challenging industry dynamics.

Navigate through the intricacies of HBM Holdings with our comprehensive valuation report here. Understand HBM Holdings' track record by examining our Past report.SEHK:2142 Ownership Breakdown as at May 2026

Next Steps

Dive into all 64 of the Undervalued Asian Small Caps With Insider Buying we have identified here. Already own these companies? Bring clarity to your investment decisions by linking up your portfolio with Simply Wall St, where you can monitor all the vital signs of your stocks effortlessly. Elevate your portfolio with Simply Wall St, the ultimate app for investors seeking global market coverage.

Curious About Other Options?

Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. Find companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include ASX:GNC ASX:PRN and SEHK:2142.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email [email protected]

View Comments